Biden declares emergency in flood

LiveAgeneralviewofafloodedarea,inLudlow,Vt.,July10,2023.Instagram@henrysweatherchannel/viaReutersU.S OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof




focus

author：hotspot    Page View：37

Editor’s note: A recording of the event is embedded below.

After a few go-go years, the early-stage biotech market has cooled considerably. Two VCs will weigh in on what distinguishes great science from bad investments.

advertisement

Featured Speakers

  • Irena Melnikova, Ph.D., partner, Pfizer Ventures
  • Rakhshita Dhar, senior director, venture investments, Leaps by Bayer
  • Frank S. David, M.D., Ph.D., managing director, Pharmagellan (moderator)

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In
Previous article： Care demand spikes challenge UnitedHealth’s provider arm
Next article： Medical records are filled with copy